EP2957292
Meðferð við skjallblettum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
27.3.2009EP published:
13.12.2017EP application number:
15170572.0
EP translation filed:
15.1.2018Grant published:
15.2.2018EPO information:
European Patent Register
Max expiry date:
26.3.2029
Title:
THERAPY FOR VITILIGO
Timeline
Today
27.3.2009EP application
13.12.2017EP Publication
15.1.2018Translation submitted
15.2.2018Registration published
Owner
Name:
Clinuvel Pharmaceuticals LimitedAddress:
Level 6, 15 Queen Street, 3000, Melbourne, VIC, AU
Inventor
Name:
Wolgen, PhilippeAddress:
Melbourne, Victoria, AU
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
2008901461Date:
27.3.2008Country:
AU
Classification
Categories:
A61K 38/13, A61K 38/21, A61K 38/34, A61K 9/00, A61K 31/37, A61K 31/436, A61K 31/485, A61K 31/505, A61K 31/52, A61K 31/573, A61K 31/58, A61K 45/06, A61N 5/06, C07K 14/685, A61P 17/00